bpc-157 injection site near injury evidence – No Proof Required! | Office for Science and Society Strengths:30 mg Methylation AOD 9604 Side Effects

bpc-157 injection site near injury evidence – No Proof Required! | Office for Science and Society Strengths:30 mg Methylation AOD 9604 Side Effects

AOD 9604 Side Effects You Should Know About - Uptown Medical Wellness & Anti-Aging Center

The statement is true, but very misleading as it is made to sound that larger TSI-drift papers were ignored

Methylation

Strengths:30 mg

Here’s how they work together: Folate’s role: Dietary folate converts to 5-MTHF (active folate) via the MTHFR enzyme 5-MTHF donates a methyl group to homocysteine This requires B12 as a cofactor for the enzyme methionine synthase The result: homocysteine converts to methionine B12’s role: B12 (as methylcobalamin) acts as a cofactor for methionine synthase It helps transfer the methyl group from 5-MTHF to homocysteine Without adequate B12, folate gets “trapped” and can’t donate its methyl group This is called the “methyl trap” What happens when one is deficient: Low B12 with adequate folate: Folate can’t function properly (methyl trap) Homocysteine rises despite good folate levels Methylation slows down Can mask B12 deficiency symptoms initially Low folate with adequate B12: Not enough methyl groups available for donation Homocysteine rises Methylation impaired DNA synthesis affected Both low: Severe methylation impairment Very high homocysteine Anemia (megaloblastic) Neurological damage risk Why MTHFR mutations affect this partnership: With MTHFR mutations: Your body can’t efficiently convert folate to 5-MTHF This creates a bottleneck in the methylation cycle Even with adequate B12, you don’t have enough active folate to work with it Result: elevated homocysteine, poor methylation The solution: Bypass the MTHFR bottleneck by taking pre-methylated folate (5-MTHF) that doesn’t require conversion